Terms: = Skin cancer AND FCGR2B, FCGR2, 2213, ENSG00000072694, CD32, CD32B, P31994, IGFR2, FCG2 AND Treatment
4 results:
1. Association of treatment Facility Characteristics With Overall Survival After Mohs Micrographic Surgery for T1a-T2a Invasive Melanoma.
Cheraghlou S; Christensen SR; Leffell DJ; Girardi M
JAMA Dermatol; 2021 May; 157(5):531-539. PubMed ID: 33787836
[TBL] [Abstract] [Full Text] [Related]
2. Talimogene Laherparepvec for the treatment of Advanced Melanoma.
Ott PA; Hodi FS
Clin Cancer Res; 2016 Jul; 22(13):3127-31. PubMed ID: 27146699
[TBL] [Abstract] [Full Text] [Related]
3. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
Vieyra-Garcia PA; Wei T; Naym DG; Fredholm S; Fink-Puches R; Cerroni L; Odum N; O'Malley JT; Gniadecki R; Wolf P
Clin Cancer Res; 2016 Jul; 22(13):3328-39. PubMed ID: 26851186
[TBL] [Abstract] [Full Text] [Related]
4. A multi-factorial genetic model for prognostic assessment of high risk melanoma patients receiving adjuvant interferon.
Wang E; Zhao Y; Monaco A; Uccellini L; Kirkwood JM; Spyropoulou-Vlachou M; Panelli MC; Marincola FM; Gogas H
PLoS One; 2012; 7(7):e40805. PubMed ID: 22911710
[TBL] [Abstract] [Full Text] [Related]
